Literature DB >> 31917024

Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.

Christina L Dean1, Scott M Krummey1, Howard M Gebel1, Robert A Bray1, Harold C Sullivan2.   

Abstract

Previously, a distinct MHC class II Luminex-single antigen bead (SAB) pattern was described and attributed to antibodies targeting denatured antigens. In this study, we describe a distinct MHC class I reactivity pattern observed in 1.8% (105/5992) of samples resulted in 2017. The pattern displays reactivity to the following Luminex-SABs: HLA-A*33:03, A*36:01, A*80:01, B*54:01, B*53:01, C*06:02, C*07:02, C*18:02, C*14:02, C*03:03, C*03:04, and C*15:02. This pattern was identified in patients with no sensitization history, negative FlowPRA results, and antibody to self-antigen(s). Epitope analysis failed to reveal a common determinant(s) to explain this pattern of reactivity. Additionally, we found this pattern to be prevalent in female patients (62%) and also those with systemic lupus erythematosus (62%). Given these findings, we speculate this pattern likely represents false-positive reactivity, possibly due to antibody targeting denatured antigens or a specific peptide, molecular mimicry, autoimmunity, or a combination thereof.
Copyright © 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA antibody; Luminex assay; MHC class I; Single antigen bead

Mesh:

Substances:

Year:  2020        PMID: 31917024      PMCID: PMC7357571          DOI: 10.1016/j.humimm.2019.12.006

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices.

Authors:  Afzal Nikaein; Nadim El-Awar; Judson Hunt; Edward J Rosenthal; Eric Eichhorn; Shelly Hall; James Boehrer; Mitchell Magee; Marc Pieniek; William Brinkman; Todd Dewey
Journal:  J Heart Lung Transplant       Date:  2011-11-10       Impact factor: 10.247

2.  Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.

Authors:  Nadim El-Awar; Paul I Terasaki; Anh Nguyen; Nori Sasaki; Luis E Morales-Buenrostro; Hiroh Saji; Etsuko Maruya; Francesca Poli
Journal:  Hum Immunol       Date:  2009-07-04       Impact factor: 2.850

3.  Antibodies against denatured HLA class II molecules detected in luminex-single antigen assay.

Authors:  Patricia C Grenzi; Renato de Marco; Rosemeire Z R Silva; Erika F Campos; Maria Gerbase-DeLima
Journal:  Hum Immunol       Date:  2013-07-02       Impact factor: 2.850

4.  The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation.

Authors:  H G Otten; M C Verhaar; H P E Borst; M van Eck; W G J van Ginkel; R J Hené; A D van Zuilen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

5.  General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.

Authors:  G Schlaf; C Mauz-Körholz; U Ott; S Leike; W Altermann
Journal:  Histol Histopathol       Date:  2012-01       Impact factor: 2.303

6.  Epitope analysis of HLA-DQ antigens: what does the antibody see?

Authors:  Anat R Tambur; Jimmy Rosati; Shirley Roitberg; Denis Glotz; John J Friedewald; Joseph R Leventhal
Journal:  Transplantation       Date:  2014-07-27       Impact factor: 4.939

7.  "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males.

Authors:  Luis E Morales-Buenrostro; Paul I Terasaki; Lluvia A Marino-Vázquez; Jar-How Lee; Nadim El-Awar; Josefina Alberú
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

8.  (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.

Authors:  Harold C Sullivan; Christina L Dean; Robert S Liwski; Shilpee Biswas; Abigail L Goodman; Scott Krummey; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2018-08-03       Impact factor: 2.850

Review 9.  Understanding solid-phase HLA antibody assays and the value of MFI.

Authors:  Harold C Sullivan; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2017-05-30       Impact factor: 2.850

10.  cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.

Authors:  K J Tinckam; R Liwski; D Pochinco; M Mousseau; A Grattan; P Nickerson; P Campbell
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

View more
  2 in total

1.  The utility of second single antigen bead assay: Clearing the water or stirring up mud?

Authors:  Harold C Sullivan; Scott M Krummey; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2020-10-06       Impact factor: 2.850

2.  Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination.

Authors:  Qingyong Xu; Puneet Sood; Dennis Helmick; Jon S Lomago; Amit D Tevar; Adriana Zeevi
Journal:  Am J Transplant       Date:  2021-07-19       Impact factor: 9.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.